Statement from Breakthrough T1D on FTC Action and Congressional PBM Reforms Impacting Insulin Affordability
February 10, 2026
February 10, 2026
NEW YORK, Feb. 10 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:
* * *
Statement from Breakthrough T1D on FTC Action and Congressional PBM Reforms Impacting Insulin Affordability
*
Breakthrough T1D applauds recent action by the Federal Trade Commission (FTC) to finalize a settlement with Express Scripts, one of the nation's largest pharmacy benefit managers . . .
* * *
Statement from Breakthrough T1D on FTC Action and Congressional PBM Reforms Impacting Insulin Affordability
*
Breakthrough T1D applauds recent action by the Federal Trade Commission (FTC) to finalize a settlement with Express Scripts, one of the nation's largest pharmacy benefit managers . . .